ロード中...
FK506 augments activation-induced programmed cell death of T lymphocytes in vivo.
FK506 is an immunosuppressive drug that inhibits T cell receptor-mediated signal transduction. This drug can induce immunological tolerance in allograft recipients. In this study, we investigated the in vivo effects of FK506 on T cell receptor-mediated apoptosis induction. Injection of anti-CD3 anti...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC185256/ https://ncbi.nlm.nih.gov/pubmed/7543492 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|